Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2018 | 03-2017 | 03-2016 | 03-2015 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,797 | -4,377 | -2,010 | -3,878 | -2,547 |
| Depreciation Amortization | 294 | 274 | 123 | N/A | N/A |
| Income taxes - deferred | -242 | -227 | -661 | N/A | N/A |
| Accounts receivable | -48 | 154 | -117 | N/A | N/A |
| Other Working Capital | -371 | 324 | -173 | 277 | -430 |
| Other Operating Activity | 1,131 | 1,232 | 722 | 257 | 191 |
| Operating Cash Flow | $-5,033 | $-2,620 | $-2,116 | $-3,345 | $-2,786 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -10 | -30 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -306 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -51 | -191 | N/A | N/A |
| Other Investing Activity | 0 | -186 | -191 | 551 | 0 |
| Investing Cash Flow | $-40 | $-196 | $-526 | $551 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 108 | -299 | 51 | N/A | N/A |
| Debt Issued | N/A | N/A | 1,948 | N/A | N/A |
| Debt Repayment | N/A | N/A | -37 | N/A | N/A |
| Common Stock Issued | 6,941 | 3,329 | 958 | 921 | 7,262 |
| Other Financing Activity | -221 | 632 | -286 | -513 | -1,093 |
| Financing Cash Flow | $6,828 | $3,661 | $2,634 | $408 | $6,169 |
| Exchange Rate Effect | -21 | 5 | N/A | N/A | N/A |
| Beginning Cash Position | 1,172 | 294 | 303 | 2,736 | 185 |
| End Cash Position | 2,907 | 1,144 | 295 | 350 | 3,568 |
| Net Cash Flow | $1,735 | $850 | $-8 | $-2,386 | $3,383 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,033 | -2,620 | -2,116 | -3,345 | -2,786 |
| Capital Expenditure | -40 | -10 | -30 | N/A | N/A |
| Free Cash Flow | -5,072 | -2,631 | -2,146 | -3,345 | -2,786 |